Literature DB >> 7583676

6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death.

B S Jeon1, V Jackson-Lewis, R E Burke.   

Abstract

The 6-hydroxydopamine (6-OHDA) model of nigral injury in rats has been in use as a standard animal model of parkinsonism for many years. While earlier studies established the time course for loss of catecholamine histofluorescence or tyrosine hydroxylase immunostaining in the cell bodies and terminals, these alterations in phenotypic expression do not define the time course of morphologic degeneration. We have therefore used a silver impregnation method to characterize the time course and morphology of the degeneration of neurons in the nigrostriatal system. Abundant neuronal death was observed in substantia nigra pars compacta (SNpc) as early as 12 hours after nigral 6-OHDA injection, and prior to any evidence of striatal terminal degeneration. From 1 to 7 days neuron death was accompanied by striatal fibre degeneration. After 7 days, fibre degeneration was no longer seen, but identifiable neuron death continued at low levels for as long as 31 days, and stained amorphous material was present at 60 days. The morphologic pattern of cell death in the early phase was similar to that in the late phase, and included cytoplasmic silver deposits and dark staining of the nucleolus. At no time was the morphology of apoptosis observed. We conclude that neuron death is a progressive process following 6-OHDA lesion, with similar morphology throughout the course of degeneration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583676     DOI: 10.1006/neur.1995.0016

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  62 in total

Review 1.  Parkinson's disease: a rethink of rodent models.

Authors:  Heather L Melrose; Sarah J Lincoln; Glenn M Tyndall; Matthew J Farrer
Journal:  Exp Brain Res       Date:  2006-04-26       Impact factor: 1.972

2.  Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Authors:  Eleni Antzoulatos; Michael W Jakowec; Giselle M Petzinger; Ruth I Wood
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

3.  Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.

Authors:  M P Smith; W A Cass
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

4.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

5.  Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease.

Authors:  Sofía Sánchez-Iglesias; Pablo Rey; Estefanía Méndez-Alvarez; José Luis Labandeira-García; Ramón Soto-Otero
Journal:  Neurochem Res       Date:  2006-12-12       Impact factor: 3.996

6.  Neuroprotective Role of MicroRNA-22 in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via Regulation of Its Target Gene TRPM7.

Authors:  Chao Ping Yang; Zhen Hua Zhang; Li Hua Zhang; Han Chen Rui
Journal:  J Mol Neurosci       Date:  2016-09-08       Impact factor: 3.444

7.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

8.  Quantifying muscle alterations in a Parkinson's disease animal model using electromyographic biomarkers.

Authors:  Pablo Y Teruya; Fernando D Farfán; Álvaro G Pizá; Jorge H Soletta; Facundo A Lucianna; Ana L Albarracín
Journal:  Med Biol Eng Comput       Date:  2021-07-23       Impact factor: 2.602

9.  Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic.

Authors:  T F Oo; R Blazeski; S M Harrison; C Henchcliffe; C A Mason; S K Roffler-Tarlov; R E Burke
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

Review 10.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.